Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages 2396-2403

  Yoshihara, Ai ^a   Noh, Jaeduk Yoshimura ^a   Yamaguchi, Takuhiro ^b   Ohye, Hidemi ^a   Sato, Shiori ^a   Sekiya, Kenichi ^a   Kosuga, Yuka ^a   Suzuki, Miho ^a   Matsumoto, Masako ^a   Kunii, Yo ^a   Watanabe, Natsuko ^a   Mukasa, Koji ^a   Ito, Kunihiko ^a   Ito, Koichi ^a  

^a ITO HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; LEVOTHYROXINE; POTASSIUM IODIDE; PROPYLTHIOURACIL; THIAMAZOLE; THYROXINE;

ADULT; ANUS ATRESIA; AORTA STENOSIS; ARACHNOID CYST; ARTICLE; BILE DUCT ATRESIA; BONE DISEASE; BRACHYDACTYLY; CLEFT LIP; CLEFT PALATE; CONGENITAL CATARACT; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DIAPHRAGM HERNIA; DISEASE ASSOCIATION; EAR MALFORMATION; ESOPHAGUS ATRESIA; ESOPHAGUS STENOSIS; FALLOT TETRALOGY; FEMALE; FIRST TRIMESTER PREGNANCY; GRAVES DISEASE; GREAT VESSELS TRANSPOSITION; HEARING LOSS; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYDRONEPHROSIS; HYPERTHYROIDISM; HYPOSPADIAS; INTESTINE MALROTATION; KIDNEY DYSPLASIA; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEGACOLON; MESENTERY DISEASE; NEWBORN; OCCULT SPINAL DYSRAPHISM; OMPHALOCELE; OMPHALOMESENTERIC DUCT ANOMALY; PATELLA HYPOPLASIA; PATENT DUCTUS ARTERIOSUS; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; SITUS INVERSUS; SKIN APLASIA; SMALL INTESTINE OBSTRUCTION; STURGE WEBER SYNDROME; SYNDACTYLY; THYROIDECTOMY; TRISOMY 21; VALGUS DEFORMITY; VARUS DEFORMITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTITHYROID AGENTS; CASE-CONTROL STUDIES; FEMALE; GRAVES DISEASE; HUMANS; INFANT, NEWBORN; LIVE BIRTH; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; PROPYLTHIOURACIL; YOUNG ADULT;

EID: 84863600669     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2860     Document Type: Article

References (34)

1. Ecker JL, Musci TJ 1997 Treatment of thyroid disease in pregnancy. Obstet Gynecol Clin North Am 24:575-589 (Pubitemid 27333105)
2. Mestman JH 2004 Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 18:267-288
3. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, Vannasaeng S, Nitiyanant W, Boonnamsiri V, Vichayanrat A 2001 Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf) 54:365-370 (Pubitemid 32234201)
4. Lazarus JH, Kokandi A 2000 Thyroid disease in relation to pregnancy: a decade of change. Clin Endocrinol (Oxf) 53:265-278
5. Luewan S, Chakkabut P, Tongsong T 2011 Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet 283:243-247
6. Galofre JC, Davies TF 2009 Autoimmune thyroid disease in pregnancy: a review. J Womens Health (Larchmt) 18:1847-1856
7. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, Mimura T 1984 Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf) 20:695-700 (Pubitemid 14105342)
8. Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I 1997 Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 82:3099-3102 (Pubitemid 27385681)
9. Myers AK, Reardon W 2005 Choanal atresia - a recurrent feature of foetal carbimazole syndrome. Clin Otolaryngol 30:375-377 (Pubitemid 41075983)
10. Wilson LC, Kerr BA, Wilkinson R, Fossard C, Donnai D 1998 Choanal atresia and hypothelia following methimazole exposure in utero: a second report. Am J Med Genet 75:220-222 (Pubitemid 28034506)
11. Wolf D, Foulds N, Daya H 2006 Antenatal carbimazole and choanal atresia: a new embryopathy. Arch Otolaryngol Head Neck Surg 132:1009-1011 (Pubitemid 44423385)
12. Mandel SJ, Brent GA, Larsen PR 1994 Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 4:129-133 (Pubitemid 24145896)
13. Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P 2010 Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 95:E337-E341
14. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R 1999 Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83:43-46 (Pubitemid 29104474)
15. Greenberg F 1987 Choanal atresia and athelia: methimazole teratogenicity or a new syndrome? Am J Med Genet 28:931-934 (Pubitemid 17163764)
16. Ramírez A, Espinosa de los Monteros A, Parra A, De León B 1992 Esophageal atresia and tracheoesophageal fistula in two infants born to hyperthyroid women receiving methimazole (Tapazol) during pregnancy. Am J Med Genet 44:200-202
17. Aramaki M, Hokuto I, Matsumoto T, Ishimoto H, Inoue M, Kimura T, Oikawa Y, Ikeda K, Yoshimura Y, Takahashi T, Kosaki K 2005 Iridic and retinal coloboma associated with prenatal methimazole exposure. Am J Med Genet A 139A:156-158 (Pubitemid 46211254)
18. Milham Jr S 1985 Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy. Teratology 32:321 (Pubitemid 15234527)
19. Milham Jr S, Elledge W 1972 Maternal methimazole and congenital defects in children. Teratology 5:125
20. Dutertre JP, Jonville AP, Moraine C, Autret E 1991 [Aplasia cutis after exposure to carbimazole in utero]. J Gynecol Obstet Biol Reprod (Paris) 20:575-576
21. Mujtaba Q, Burrow GN 1975 Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol 46:282-286
22. Van Dijke CP, Heydendael RJ, De Kleine MJ 1987 Methimazole, carbimazole, and congenital skin defects. Ann Intern Med 106:60-61 (Pubitemid 17228310)
23. Martinez-Frias ML, Cereijo A, Rodriguez-Pinilla E, Urioste M 1992 Methimazole in animal feed and congenital aplasia cutis. Lancet 339:742-743
24. Vogt T, Stolz W, Landthaler M 1995 Aplasia cutis congenita after exposure to methimazole: a causal relationship? Br J Dermatol 133:994-996 (Pubitemid 26008945)
25. Diav-Citrin O, Ornoy A 2002 Teratogen update: antithyroid drugs - methimazole, carbimazole, and propylthiouracil. Teratology 65:38-44 (Pubitemid 34024457)
26. Cheron RG, Kaplan MM, Larsen PR, Selenkow HA, Crigler Jr JF 1981 Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. N Engl J Med 304:525-528 (Pubitemid 11056499)
27. Di Gianantonio E, Schaefer C, Mastroiacovo PP, Cournot MP, Benedicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A, Arnon J, Clementi M 2001 Adverse effects of prenatal methimazole exposure. Teratology 64:262-266 (Pubitemid 33032708)
28. Rosenfeld H, Ornoy A, Shechtman S, Diav-Citrin O 2009 Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol 68:609-617
29. Barbero P, Valdez R, Rodríguez H, Tiscornia C, Mansilla E, Allons A, Coll S, Liascovich R 2008 Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 146A:2390-2395
30. Barbero P, Ricagni C, Mercado G, Bronberg R, Torrado M 2004 Choanal atresia associated with prenatal methimazole exposure: three new patients. Am J Med Genet A 129A:83-86 (Pubitemid 38989050)
31. Pillar N, Levy A, Holcberg G, Sheiner E 2010 Pregnancy and perinatal outcome in women with hyperthyroidism. Int J Gynaecol Obstet 108:61-64
32. Chircor L, Mehedinpi R, Hîncu M 2009 Risk factors related to omphalocele and gastroschisis. Rom J Morphol Embryol 50:645-649
33. Koenig D, Spreux A, Hiéronimus S, Chichmanian RM, Bastiani F, Fénichel P, Brucker-Davis F 2010 Birth defects observed with maternal carbimazole treatment: six cases reported to Nice's Pharmacovigilance Center. Ann Endocrinol (Paris) 71:535-542
34. Durakbasa CU, Okur H, Mutus HM, Bas A, Ozen MA, Sehiralti V, Tosyali AN, Zemheri IE 2010 Symptomatic omphalomesenteric duct remnants in children. Pediatr Int 52:480-484